Novavax (NVAX) Gains as AstraZeneca's Vaccine Put on Hold

September 8, 2020 5:28 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Novavax (NASDAQ: NVAX) gains 7% as AstraZeneca (NYSE: AZN) COVID19 vaccine study put on hold due to suspected adverse reaction in participant in the UK.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Momentum Movers, Trader Talk